The clinical performance is complex and often involves multi-systematic stress. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in linking domestic and foreign authorities with teams of experts to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many genetic metabolic disorders that were previously difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustment according to changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of type VIII osteoporosis. The platform serves a team of internationally authoritative experts in the field of genetic metabolism at home and abroad in China's international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.